BOOK
SPEC - Kaufman's Clinical Neurology for Psychiatrists
David Myland Kaufman | Howard L. Geyer | Mark J Milstein
(2016)
Additional Information
Book Details
Abstract
For more than 35 years, Kaufman’s Clinical Neurology for Psychiatrists has been the only reference to focus on the must-know aspects of neurology for psychiatrists. Now in a revised 8th Edition, this classic text brings you up to date with essential knowledge in clinical neurology with new topics, new illustrations, and new questions to help you excel on the American Board of Psychiatry and Neurology examination.
- Explains each condition's neurologic and psychiatric features , easily performed office and bedside examinations, appropriate tests, differential diagnosis, and management options.
- Discusses timely, clinically-relevant topics such as traumatic brain injury, Alzheimer and non-Alzheimer dementias, other age-related neurologic conditions, neurologic illnesses that present with symptoms of autism, neurologic effects of illicit drug use, and current treatments.
- Correlates neurologic illnesses with the DSM-5.
- Includes nearly 2,000 multiple-choice questions – all written to help you succeed on the ABPN certifying exam.
- Features new and improved clinical illustrations throughout: life-like patient sketches, anatomy line drawings, CTs, MRIs, and EEGs that demonstrate clinical features.
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | cover | ||
Inside Front Cover | ifc1 | ||
Kaufman's Clinical Neurology for Psychiatrists | i | ||
Copyright Page | iv | ||
Table Of Contents | v | ||
Dedication | vii | ||
Acknowledgments | viii | ||
Notes About References | ix | ||
Web Sites That Offer Information About Several Areas | ix | ||
Physician-readers, Please Note | x | ||
Preface | xi | ||
Purpose | xi | ||
Organization and Content | xi | ||
Additions and Other Changes for the Eighth Edition | xi | ||
Didactic Devices: The Visual Approach and Question-and-Answer Sections | xii | ||
One Caveat | xii | ||
1 Classic Anatomic Neurology | 1 | ||
1 First Encounter With a Patient | 3 | ||
Examination | 3 | ||
Formulation | 4 | ||
Responding as A Neurologist to Consultations | 5 | ||
Neurologic Diagnosis | 5 | ||
2 Signs of Central Nervous System Disorders | 7 | ||
Signs of Cerebral Hemisphere Lesions | 7 | ||
Signs of Damage of the Dominant, Nondominant, or Both Cerebral Hemispheres | 7 | ||
Signs of Basal Ganglia Lesions | 11 | ||
Signs of Brainstem Lesions | 11 | ||
Signs of Cerebellar Lesions | 12 | ||
Signs of Spinal Cord Lesions | 15 | ||
Spinal Cord Transection | 15 | ||
Syringomyelia | 16 | ||
Neurologic Illnesses | 16 | ||
3 Psychogenic Neurologic Deficits | 19 | ||
Neurologist’s Role | 19 | ||
Psychogenic Deficits | 19 | ||
Motor Signs | 20 | ||
Gait Impairment | 20 | ||
Sensory Deficits | 21 | ||
Special Senses | 21 | ||
Other Conditions | 22 | ||
Potential Pitfalls | 24 | ||
References | 25 | ||
4 Cranial Nerve Impairments | 27 | ||
Olfactory (First) | 27 | ||
Optic (Second) | 28 | ||
Oculomotor, Trochlear, and Abducens Nerves (Third, Fourth, and Sixth) | 30 | ||
Trigeminal (Fifth) | 34 | ||
Facial (Seventh) | 35 | ||
Acoustic (Eighth) | 36 | ||
Glossopharyngeal, Vagus, and Spinal Accessory Nerves (Ninth, Tenth, and Eleventh) | 38 | ||
Bulbar Palsy | 39 | ||
Pseudobulbar Palsy | 40 | ||
Hypoglossal (Twelfth) | 41 | ||
Questions and Answers | 42 | ||
Preparing for Standardized Tests | 42 | ||
Questions and Answers: Chapters 1–4 | 42 | ||
5 Peripheral Nerve Disorders | 55 | ||
Anatomy | 55 | ||
Mononeuropathies | 55 | ||
Mononeuritis Multiplex | 57 | ||
Polyneuropathies (Neuropathies) | 58 | ||
Neuropathies Without Comorbid Mental Status Changes | 58 | ||
Guillain–Barré Syndrome | 58 | ||
Diabetes | 60 | ||
Toxic-Metabolic Disorders | 60 | ||
Aging | 62 | ||
Neuropathies With Comorbid Mental Status Changes | 62 | ||
Nutritional Deficiencies | 62 | ||
Medication Adverse Effects | 63 | ||
Infectious Diseases | 63 | ||
Inherited Metabolic Illnesses | 64 | ||
Volatile Substance Exposure | 64 | ||
Pseudoneurotoxic Disease | 65 | ||
Marine Toxicology | 65 | ||
Motor Neuron Disorders | 65 | ||
Amyotrophic Lateral Sclerosis | 65 | ||
Childhood-Onset Motor Neuron Diseases | 66 | ||
Poliomyelitis | 67 | ||
Benign Fasciculations | 67 | ||
Spine Disease | 67 | ||
Web Site | 69 | ||
References | 69 | ||
Questions and Answers: Chapter 5 | 71 | ||
6 Muscle Disorders | 81 | ||
Neuromuscular Junction Disorders | 81 | ||
Myasthenia Gravis | 81 | ||
Neuromuscular Transmission Impairment | 81 | ||
Clinical Features | 81 | ||
Differential Diagnosis | 82 | ||
Treatment | 83 | ||
Lambert–Eaton Syndrome | 84 | ||
Botulism | 84 | ||
Tetanus | 84 | ||
Nerve Gas and Other Wartime Issues | 84 | ||
Chronic Fatigue Syndrome and Fibromyalgia | 85 | ||
Muscle Disease (Myopathy) | 85 | ||
Inherited Dystrophies | 86 | ||
Duchenne Muscular Dystrophy | 86 | ||
Genetics. | 86 | ||
Becker Dystrophy | 86 | ||
Myotonic Dystrophy | 86 | ||
Genetics. | 87 | ||
Inflammatory and Infectious Myopathies | 88 | ||
Metabolic Myopathies | 89 | ||
Mitochondrial Myopathies | 89 | ||
Neuroleptic Malignant Syndrome | 91 | ||
Other Causes of Rhabdomyolysis, Hyperthermia, and Altered Mental States | 91 | ||
Serotonin Syndrome | 91 | ||
Malignant Hyperthermia | 92 | ||
Other Causes | 92 | ||
Laboratory Tests | 92 | ||
Nerve Conduction Studies | 92 | ||
Electromyography | 92 | ||
Serum Enzyme Determinations | 93 | ||
Muscle Biopsy | 93 | ||
References | 93 | ||
Questions and Answers: Chapter 6 | 94 | ||
2 Major Neurologic Symptoms | 103 | ||
Section Chapters | 103 | ||
Introduction | 103 | ||
7 Dementia | 105 | ||
Disorders Related to Dementia | 105 | ||
Congenital Cognitive Impairment | 105 | ||
Amnesia | 105 | ||
Transient Global Amnesia | 106 | ||
Neuropsychologic Conditions | 107 | ||
Normal Aging | 107 | ||
Memory and Other Neuropsychologic Functions | 107 | ||
Sleep | 107 | ||
Motor and Gait | 107 | ||
Special Senses | 107 | ||
EEG and Imaging Changes | 108 | ||
Macroscopic and Microscopic Changes | 108 | ||
Dementia | 108 | ||
Classifications and Causes | 108 | ||
Mental Status Testing | 109 | ||
Screening Tests | 109 | ||
Mini-Mental State Examination (Fig. 7.1). | 109 | ||
Alzheimer Disease Assessment Scale. | 109 | ||
Montreal Cognitive Assessment (Fig. 7.3). | 109 | ||
Further Testing | 109 | ||
Laboratory Evaluation in Dementia. | 110 | ||
Alzheimer Disease | 112 | ||
Preclinical Alzheimer Disease | 112 | ||
Mild Cognitive Impairment | 112 | ||
Dementia | 113 | ||
Neuropsychiatric Manifestations | 113 | ||
Physical Signs | 113 | ||
Laboratory Tests | 113 | ||
Pathology | 114 | ||
Amyloid Deposits | 115 | ||
Biochemical Abnormalities | 115 | ||
Risk Factors and Genetic Causes | 116 | ||
Genetic Causes | 117 | ||
Treatment of Dementia | 117 | ||
Treatment of Neuropsychiatric Symptoms | 118 | ||
Caregiver Stress | 118 | ||
Related Disorders | 119 | ||
Trisomy 21 | 119 | ||
Dementia With Lewy Bodies | 119 | ||
Three Core Features: | 119 | ||
Two Suggestive Features: | 119 | ||
Frontal Lobe Disorders | 119 | ||
Injuries | 119 | ||
Frontotemporal Dementia or Frontotemporal Degeneration | 120 | ||
Other Dementias | 122 | ||
Vascular Cognitive Impairment | 122 | ||
Wernicke–Korsakoff Syndrome | 122 | ||
Other Causes of Dementia in Alcoholics | 123 | ||
Medication-Induced Cognitive Deficits | 123 | ||
Normal-Pressure Hydrocephalus | 123 | ||
Infections | 124 | ||
Neurosyphilis | 124 | ||
Subacute Sclerosing Panencephalitis | 125 | ||
Creutzfeldt–Jakob and Related Diseases | 125 | ||
Prions | 125 | ||
Other Spongiform Encephalopathies | 126 | ||
Variant Creutzfeldt–Jakob Disease | 126 | ||
Lyme Disease | 126 | ||
Human Immunodeficiency Virus-Associated Dementia | 127 | ||
Manifestations | 127 | ||
Treatment | 127 | ||
Testing | 127 | ||
AIDS-Induced Cerebral Lesions | 128 | ||
Other AIDS-Related Conditions | 128 | ||
Pseudodementia | 128 | ||
Delirium/Toxic-Metabolic Encephalopathy | 129 | ||
Characteristics | 129 | ||
Risk Factors | 130 | ||
Causes | 130 | ||
General Treatments | 130 | ||
Hepatic Encephalopathy | 131 | ||
Precautions in Diagnosing Alzheimer Disease | 131 | ||
References | 131 | ||
Age-Related Changes | 131 | ||
Alzheimer Disease | 131 | ||
HIV-Associated Dementia | 132 | ||
Dementia With Lewy Bodies | 132 | ||
Depression and Pseudodementia | 132 | ||
Frontotemporal Dementia | 132 | ||
Lyme Disease | 132 | ||
Creutzfeldt–Jakob Disease and Related Illnesses | 132 | ||
Delirium (Toxic-Metabolic Encephalopathy) | 132 | ||
Vascular Cognitive Impairment | 133 | ||
Other Illnesses That Cause Dementia | 133 | ||
Questions and Answers: Chapter 7 | 134 | ||
8 Aphasia and Anosognosia | 151 | ||
Language and Dominance | 151 | ||
Handedness | 151 | ||
Music | 152 | ||
Aphasia | 152 | ||
The Perisylvian Language Arc | 152 | ||
Clinical Evaluation | 152 | ||
Nonfluent Aphasia | 154 | ||
Characteristics | 154 | ||
Localization and Etiology | 154 | ||
Associated Deficits | 154 | ||
Mixed Transcortical or Isolation Aphasia | 155 | ||
Global Aphasia | 155 | ||
Fluent Aphasia | 156 | ||
Associated Deficits | 156 | ||
Localization and Etiology | 156 | ||
Anomic Aphasia | 156 | ||
Conduction Aphasia | 157 | ||
Mental Abnormalities With Language Impairment | 157 | ||
Comorbid Depression | 157 | ||
Dementia | 157 | ||
Schizophrenia | 157 | ||
Other Disorders | 158 | ||
Disorders Related to Aphasia | 158 | ||
Dyslexia | 158 | ||
Alexia and Agraphia | 158 | ||
Gerstmann Syndrome | 158 | ||
Apraxia | 159 | ||
Nondominant Hemisphere Syndromes | 160 | ||
Hemi-Inattention | 160 | ||
Constructional Apraxia | 162 | ||
Dressing Apraxia | 162 | ||
Alien Hand Syndrome | 162 | ||
Anosognosia | 163 | ||
Aprosody | 163 | ||
Disconnection Syndromes | 163 | ||
Split-Brain Syndrome | 164 | ||
References | 165 | ||
Questions and Answers: Chapter 8 | 166 | ||
Case 1 | 166 | ||
Case 2 | 166 | ||
Case 3 | 166 | ||
Case 4 | 166 | ||
Case 5 | 166 | ||
9 Headaches | 177 | ||
Primary Headaches | 177 | ||
Tension-Type Headache | 177 | ||
Treatment | 177 | ||
Migraine | 177 | ||
Migraine With Aura | 178 | ||
Migraine Without Aura | 178 | ||
Psychiatric Comorbidity | 180 | ||
Other Subtypes of Migraine | 181 | ||
Migraine-Like Conditions: Food-Induced Headaches | 181 | ||
Medication-Induced Headaches | 182 | ||
Sex-Related Headaches | 182 | ||
Proposed Causes of Migraine | 182 | ||
Acute Treatment | 182 | ||
Preventative Treatment | 183 | ||
Chronic Daily Headache | 183 | ||
Cluster Headaches | 184 | ||
Treatment | 185 | ||
Secondary Headaches | 185 | ||
Temporal Arteritis/Giant Cell Arteritis | 185 | ||
Intracranial Mass Lesions | 185 | ||
Idiopathic Intracranial Hypertension (Pseudotumor Cerebri) | 185 | ||
Post-Dural Puncture Headache | 186 | ||
Bacterial Meningitis, Herpes Encephalitis, and Subarachnoid Hemorrhage | 186 | ||
Chronic Meningitis | 187 | ||
MAOIs and the Hypertensive Crisis | 187 | ||
Cranial Neuralgias | 187 | ||
Trigeminal Neuralgia | 187 | ||
Cause and Treatment | 187 | ||
References | 188 | ||
Questions and Answers: Chapter 9 | 189 | ||
10 Epilepsy | 197 | ||
Electroencephalogram | 197 | ||
Normal and Abnormal | 197 | ||
Seizures | 197 | ||
Toxic-Metabolic Encephalopathy | 199 | ||
Dementia | 200 | ||
Structural Lesions | 200 | ||
Altered States of Awareness | 200 | ||
Psychiatric Disturbances and Psychotropics | 201 | ||
Seizure Types | 201 | ||
Focal Seizures | 202 | ||
EEG and Etiology | 203 | ||
Focal Seizures With Impaired Consciousness or Awareness (Complex Partial Seizures) | 204 | ||
Etiology | 204 | ||
Ictal Symptoms | 204 | ||
Sex, Violence, and Aggression | 205 | ||
Immediate Postictal Symptoms | 205 | ||
Frontal Lobe Seizures | 205 | ||
Rolandic Epilepsy | 205 | ||
Testing During and Between Focal Seizures | 206 | ||
EEG | 206 | ||
Other Tests | 206 | ||
Comorbid Conditions and Their Treatment | 206 | ||
Depression | 206 | ||
Bipolar Disorder | 207 | ||
Anxiety | 207 | ||
Psychosis | 208 | ||
Cognitive Impairment | 208 | ||
Destructive Behavior | 209 | ||
Suicide | 209 | ||
Crime and Interictal Violence | 209 | ||
Personality Traits | 209 | ||
Delirium | 209 | ||
Treatment | 210 | ||
AEDs | 210 | ||
AEDs and Hepatic Enzymes | 210 | ||
Cognitive and Related Side Effects | 211 | ||
Physical Side Effects | 211 | ||
AEDs and Pregnancy | 211 | ||
Vagus Nerve Stimulation | 212 | ||
Brain Resection Surgery | 212 | ||
Generalized Seizures | 213 | ||
Absence Seizures | 213 | ||
EEG, Etiology, and Treatment | 214 | ||
Tonic-Clonic Seizures | 214 | ||
Etiology | 215 | ||
Treatment | 216 | ||
Febrile Seizures | 216 | ||
Landau–Kleffner Syndrome | 216 | ||
Nonepileptic Conditions | 216 | ||
Psychogenic Nonepileptic Seizures | 216 | ||
Intermittent Explosive Disorder | 217 | ||
Related Issues | 217 | ||
Driving | 217 | ||
Alcohol | 218 | ||
Cerebrovascular Disease | 218 | ||
Sleep Disorders | 218 | ||
Metabolic Aberrations | 218 | ||
Sudden Unexplained Death in Epilepsy | 218 | ||
References | 218 | ||
AEDs | 218 | ||
Surgery | 219 | ||
Vagus Nerve Stimulation | 219 | ||
Interictal Comorbidities and Their Treatment | 219 | ||
Psychogenic Nonepileptic Seizures | 219 | ||
Seizures and Epilepsy | 219 | ||
Testing | 220 | ||
Questions and Answers: Chapter 10 | 221 | ||
11 TIAs and Strokes | 235 | ||
Transient Ischemic Attacks | 235 | ||
Carotid Artery TIAs | 235 | ||
Laboratory Tests | 235 | ||
Preventative Measures | 236 | ||
Basilar Artery TIAs | 237 | ||
Stroke | 237 | ||
Risk Factors | 238 | ||
Psychiatric Risk Factors for Stroke | 240 | ||
Thrombosis and Embolus | 240 | ||
Necrosis | 240 | ||
Infarctions in the Carotid Artery Distribution | 240 | ||
Infarctions in the Basilar Artery Distribution | 241 | ||
Hemorrhages | 241 | ||
Neuropsychologic Sequelae | 242 | ||
Poststroke Depression | 242 | ||
Other Psychiatric Complications | 243 | ||
Altered Levels of Consciousness | 243 | ||
Locked-in Syndrome | 243 | ||
Persistent Vegetative State | 244 | ||
Minimally Conscious State | 245 | ||
Managing Stroke | 245 | ||
Laboratory Tests | 245 | ||
Therapy | 245 | ||
References | 246 | ||
Questions and Answers: Chapter 11 | 248 | ||
Appendix 1 Patient and Family Support Groups | 537 | ||
General Resources | 537 | ||
Acquired Immune Deficiency Syndrome (AIDS) | 537 | ||
Alzheimer Disease | 537 | ||
Amyotrophic Lateral Sclerosis (ALS) | 537 | ||
Aphasia and Related Disorders | 537 | ||
Autism | 537 | ||
Blepharospasm | 537 | ||
Blindness | 537 | ||
Brain Tumors | 537 | ||
Cerebral Palsy | 537 | ||
Dystonia | 537 | ||
Epilepsy | 537 | ||
Fraudulent Therapies | 537 | ||
Guillain–Barré Syndrome | 537 | ||
Huntington Disease | 537 | ||
Migraine and Headache | 537 | ||
Multiple Sclerosis | 538 | ||
Muscular Dystrophy and Related Disorders | 538 | ||
Myasthenia Gravis | 538 | ||
Neurofibromatosis | 538 | ||
Pain | 538 | ||
Paraplegia | 538 | ||
Parkinson Disease | 538 | ||
Postpolio Syndrome | 538 | ||
Rett Syndrome | 538 | ||
Sleep Disorders | 538 | ||
Spasmodic Dysphonia | 538 | ||
Spasmodic Torticollis | 538 | ||
Spina Bifida | 538 | ||
Spinal Cord Injury | 538 | ||
Stroke | 538 | ||
Stuttering | 538 | ||
Tourette Syndrome | 538 | ||
Traumatic Brain Injury | 538 | ||
Tuberous Sclerosis | 538 | ||
Tremor | 538 | ||
Wilson Disease | 538 | ||
Appendix 2 Costs of Various Tests and Treatments* | 539 | ||
Appendix 3 Diseases Transmitted by Chromosome or Mitochondria Abnormalities | 541 | ||
Appendix 4 Chemical and Biological Neurotoxins | 543 | ||
Additional Review Questions and Answers | 545 | ||
Index | 641 | ||
A | 641 | ||
B | 643 | ||
C | 644 | ||
D | 646 | ||
E | 648 | ||
F | 649 | ||
G | 649 | ||
H | 650 | ||
I | 651 | ||
J | 652 | ||
K | 652 | ||
L | 652 | ||
M | 653 | ||
N | 655 | ||
O | 656 | ||
P | 657 | ||
Q | 659 | ||
R | 659 | ||
S | 660 | ||
T | 662 | ||
U | 663 | ||
V | 664 | ||
W | 664 | ||
X | 664 | ||
Y | 664 | ||
Z | 664 | ||
Inside Back Cover | ibc1 |